NF
AEMD icon

NTB Financial’s Aethlon Medical AEMD Stock Holding History

NTB Financial’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$24K Buy
27
+3
+13% +$2.79K 0.02% 142
2022
Q1 		$28K Buy
24
+2
+9% +$2.39K 0.02% 152
2021
Q4 		$32K Buy
+22
New +$50.1K 0.02% 147

Other funds holding AEMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CFN
Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

NTB Financial's AEMD Position: Q2 2022 in Review

NTB Financial increased its Aethlon Medical (AEMD) stake by 13% in Q2 2022, buying an estimated $2.79K and bringing the position to 27 shares worth $24K. The position accounts for 0.02% of the portfolio, ranked #142.

NTB Financial first reported a position in AEMD in Q4 2021 and has held it in 3 quarters since. The position peaked at $32K in Q4 2021. 22 funds tracked by Wall St. Rank hold AEMD as of Q2 2022.

  • NTB Financial held 27 shares of Aethlon Medical worth $24K as of Q2 2022.
  • NTB Financial bought 3 Aethlon Medical shares in Q2 2022, an estimated $2.79K.
  • Aethlon Medical made up 0.02% of NTB Financial's portfolio in Q2 2022, its #142 holding.
  • NTB Financial first reported a position in Aethlon Medical in Q4 2021 and has held it in 3 quarters since.
  • NTB Financial's Aethlon Medical position peaked at $32K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2022.

Based on NTB Financial's 13F filing for Q2 2022, filed 9 Aug 2022.